Our Terms of Service and Privacy Policy have changed.
By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.
By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.
| 0.16 Delayed Data As of Aug 21 |  0.00 / 0.00%Today’s Change | 0.10 Today|||52-Week Range 1.10 | -76.12% Year-to-Date |
| Previous close | 0.16 |
| Today’s open | n.a. |
| Day’s range | -- - -- |
| Volume | 0 |
| Average volume (3 months) | 9,376 |
| Market cap | $1.2M |
| Dividend yield | -- |
| Earnings growth (last year) | +36.92% |
| Earnings growth (this year) | -- |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -- |
| P/E ratio | NM |
| Price/Sales | -- |
| Price/Book | -- |
| No competitors data available. |
| Next reporting date | -- |
| EPS forecast (this quarter) | -- |
| Annual revenue (last year) | $0.00 |
| Annual profit (last year) | -$2.4M |
| Net profit margin | -- |
Sector Health Technology |
Industry Biotechnology |
President & Director Eric A. Clemons |
Chief Financial Officer, Secretary & Director Wesley D. Tate |
Corporate headquarters Costa Mesa, California |
